FDA Clearance Tracker · P010022
COSEAL SURGICAL SEALANT (COSEAL)
Last checked: Nov 20, 2026Latest source record: Dec 14, 2001 (this decision)Source: openFDAMethods & limitations
Decided
Dec 14, 2001
Approval withdrawn
Time to decision
246 days
Received Apr 12, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P010022
- Device name
- COSEAL SURGICAL SEALANT (COSEAL)
- Applicant location
- Gainesville, FL
- Received
- Apr 12, 2001
- Decided
- Dec 14, 2001
- Decision
- Approval withdrawn
- Supplements
- 3 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Sealant, polymerizing (NBE)
- Device class
- Class III
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE COSEAL SURGICAL SEALANT. THIS DEVICE IS INDICATED FOR USE IN VASCULAR RECONSTRUCTIONS TO ACHIEVE ADJUNCTIVE HEMOSTASIS BY MECHANICALLY SEALING AREAS OF LEAKAGE.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NBE. The earliest in FDA's data is P990028, decided May 26, 2000.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Angiotech Medical Device Technologies
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.